loading
前日終値:
$11.05
開ける:
$11.02
24時間の取引高:
1.95M
Relative Volume:
0.97
時価総額:
$967.13M
収益:
$139.71M
当期純損益:
$-209.36M
株価収益率:
-3.8986
EPS:
-2.96
ネットキャッシュフロー:
$-160.60M
1週間 パフォーマンス:
+9.70%
1か月 パフォーマンス:
-11.50%
6か月 パフォーマンス:
-41.98%
1年 パフォーマンス:
-44.36%
1日の値動き範囲:
Value
$10.81
$11.57
1週間の範囲:
Value
$10.15
$11.61
52週間の値動き範囲:
Value
$9.66
$25.07

Syndax Pharmaceuticals Inc Stock (SNDX) Company Profile

Name
名前
Syndax Pharmaceuticals Inc
Name
セクター
Healthcare (1151)
Name
電話
781-419-1400
Name
住所
35 GATEHOUSE DRIVE, WALTHAM, MA
Name
職員
184
Name
Twitter
@syndax
Name
次回の収益日
2025-03-03
Name
最新のSEC提出書
Name
SNDX's Discussions on Twitter

SNDX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
SNDX
Syndax Pharmaceuticals Inc
11.54 967.13M 139.71M -209.36M -160.60M -2.96
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
489.10 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.16 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
596.20 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
234.56 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
230.98 26.16B 3.81B -644.79M -669.77M -6.24

Syndax Pharmaceuticals Inc Stock (SNDX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-10-24 開始されました UBS Buy
2024-06-28 開始されました Jefferies Buy
2024-01-31 ダウングレード Scotiabank Sector Outperform → Sector Perform
2023-12-22 開始されました Mizuho Buy
2023-10-25 開始されました BofA Securities Buy
2023-10-11 開始されました Goldman Buy
2023-07-27 開始されました Scotiabank Sector Outperform
2023-07-11 開始されました Guggenheim Buy
2023-04-17 再開されました BTIG Research Buy
2023-01-31 開始されました Stifel Buy
2023-01-03 開始されました JP Morgan Overweight
2022-07-28 再開されました B. Riley Securities Buy
2022-04-11 開始されました H.C. Wainwright Buy
2022-02-15 開始されました Goldman Buy
2021-06-04 再開されました Robert W. Baird Outperform
2021-05-25 開始されました Citigroup Buy
2021-02-18 開始されました B. Riley Securities Buy
2020-12-03 開始されました Stifel Buy
2020-05-22 アップグレード Citigroup Neutral → Buy
2020-05-22 ダウングレード H.C. Wainwright Buy → Neutral
2020-05-18 ダウングレード Citigroup Buy → Neutral
2020-05-11 繰り返されました H.C. Wainwright Buy
2020-03-04 開始されました Barclays Overweight
2020-01-13 繰り返されました H.C. Wainwright Buy
2019-03-08 繰り返されました H.C. Wainwright Buy
2019-01-04 開始されました Robert W. Baird Outperform
2018-01-05 開始されました B. Riley FBR, Inc. Buy
2017-03-16 開始されました FBR & Co. Outperform
2017-03-02 開始されました Instinet Buy
2016-10-07 開始されました Guggenheim Buy
2016-03-28 開始されました Citigroup Buy
2016-03-28 開始されました JMP Securities Mkt Outperform
2016-03-28 開始されました Morgan Stanley Overweight
すべてを表示

Syndax Pharmaceuticals Inc (SNDX) 最新ニュース

pulisher
05:06 AM

Walleye Capital LLC Has $4.82 Million Stock Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

05:06 AM
pulisher
01:00 AM

(SNDX) On The My Stocks Page - news.stocktradersdaily.com

01:00 AM
pulisher
Apr 18, 2025

Sei Investments Co. Lowers Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

Apr 18, 2025
pulisher
Apr 15, 2025

StockNews.com Upgrades Syndax Pharmaceuticals (NASDAQ:SNDX) to "Sell" - MarketBeat

Apr 15, 2025
pulisher
Apr 14, 2025

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Sold by ExodusPoint Capital Management LP - MarketBeat

Apr 14, 2025
pulisher
Apr 13, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Shares Down 6.6%Time to Sell? - MarketBeat

Apr 13, 2025
pulisher
Apr 13, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Reaches New 52-Week LowHere's Why - MarketBeat

Apr 13, 2025
pulisher
Apr 12, 2025

Sei Investments Co. Sells 35,414 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World

Apr 12, 2025
pulisher
Apr 11, 2025

Barclays Adjusts Price Target for Syndax (SNDX) Ahead of Q1 Earnings | SNDX Stock News - GuruFocus

Apr 11, 2025
pulisher
Apr 11, 2025

Vanguard Group Inc. Sells 5,006 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World

Apr 11, 2025
pulisher
Apr 11, 2025

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Apr 11, 2025
pulisher
Apr 10, 2025

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Sold by Rhenman & Partners Asset Management AB - MarketBeat

Apr 10, 2025
pulisher
Apr 10, 2025

Trexquant Investment LP Buys 437,859 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

Apr 10, 2025
pulisher
Apr 10, 2025

Bryce Point Capital LLC Makes New Investment in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

Apr 10, 2025
pulisher
Apr 10, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Raised to “Sell” at StockNews.com - Defense World

Apr 10, 2025
pulisher
Apr 09, 2025

SNDX stock touches 52-week low at $10.14 amid market challenges By Investing.com - Investing.com South Africa

Apr 09, 2025
pulisher
Apr 09, 2025

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Sold by Wellington Management Group LLP - MarketBeat

Apr 09, 2025
pulisher
Apr 09, 2025

Syndax at Stifel Forum: Strategic Drug Launches By Investing.com - Investing.com Canada

Apr 09, 2025
pulisher
Apr 08, 2025

Corebridge Financial Inc. Has $540,000 Stock Holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World

Apr 08, 2025
pulisher
Apr 07, 2025

Syndax Pharmaceuticals: Down But Not Out (NASDAQ:SNDX) - Seeking Alpha

Apr 07, 2025
pulisher
Apr 07, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Trading 4.7% HigherStill a Buy? - MarketBeat

Apr 07, 2025
pulisher
Apr 07, 2025

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World

Apr 07, 2025
pulisher
Apr 06, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Rating Increased to Sell at StockNews.com - MarketBeat

Apr 06, 2025
pulisher
Apr 06, 2025

Axiom Investors LLC DE Sells 62,418 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

Apr 06, 2025
pulisher
Apr 05, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Sets New 12-Month LowWhat's Next? - MarketBeat

Apr 05, 2025
pulisher
Apr 05, 2025

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - The Manila Times

Apr 05, 2025
pulisher
Apr 04, 2025

Syndax Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com

Apr 04, 2025
pulisher
Apr 03, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Trading Down 7.5%Should You Sell? - MarketBeat

Apr 03, 2025
pulisher
Apr 02, 2025

How the (SNDX) price action is used to our Advantage - news.stocktradersdaily.com

Apr 02, 2025
pulisher
Apr 02, 2025

Syndax Announces Participation at the Stifel 2025 Virtual Targeted Oncology Forum - GlobeNewswire

Apr 02, 2025
pulisher
Apr 02, 2025

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Purchased by Teacher Retirement System of Texas - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Raised to Sell at StockNews.com - Defense World

Apr 02, 2025

Syndax Pharmaceuticals Inc (SNDX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.04
price up icon 2.51%
$72.65
price up icon 3.49%
$32.60
price up icon 1.27%
$24.61
price up icon 6.77%
$98.76
price up icon 0.52%
biotechnology ONC
$230.98
price up icon 1.24%
大文字化:     |  ボリューム (24 時間):